Novanta to present at Baird Global Healthcare Conference
Get Alerts NOVT Hot Sheet
Join SI Premium – FREE
BEDFORD, Mass., Aug. 18, 2017 /PRNewswire/ -- Novanta Inc. (NASDAQ: NOVT), a trusted technology partner to medical and advanced technology equipment manufacturers, will present at the 2017 Baird Global Healthcare Conference at the Intercontinental Hotel in New York City. The Company's presentation will be on Thursday, September 7, 2017. Matthijs Glastra, Novanta's Chief Executive Officer, and Robert Buckley, Novanta's Chief Financial Officer, will attend the conference.
A copy of the presentation to be presented will be available on the Investor Relations section of the Company's website at www.novanta.com.
About Novanta
Novanta is a leading global supplier of core technology solutions that give healthcare and advanced industrial original equipment manufacturers ("OEMs") a competitive advantage. We combine deep proprietary expertise in photonics, vision, and precision motion technologies with a proven ability to solve complex technical challenges. This enables Novanta to engineer mission-critical core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta's common shares are quoted on NASDAQ under the ticker symbol "NOVT".
More information about Novanta is available on the Company's website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or [email protected].
Novanta Inc.Investor Relations Contact:Robert J. Buckley(781) 266-5137
* * *

View original content with multimedia:http://www.prnewswire.com/news-releases/novanta-to-present-at-baird-global-healthcare-conference-300506642.html
SOURCE Novanta Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Starts Cohu (COHU) at Outperform
- Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment
- Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share